Please Wait.....
Report
Respiratory Care Devices Market By Product (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables and Accessories) , By End User (Hospitals, Home Care) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 350 Pages I Allied Market Research
The respiratory care devices market was valued at $22.9 billion in 2023, and is projected to reach $47.9 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
Respiratory care device is a medical device that supports breathing by delivering controlled amounts of oxygen to patients who cannot breathe adequately on their own. These devices are crucial in the treatment and management of various respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and respiratory infections. They play a vital role in both acute and chronic respiratory care and improving patients' quality of life.
The growth of the global respiratory care devices market is majorly driven by alarming rise in prevalence of respiratory diseases and need for cutting-edge respiratory care devices. Increase in air pollution, sedentary lifestyles, smoking & tobacco use, and lack of physical activity have led to increase in cases of respiratory diseases. According to a study published by the World Health Organization in March 2023, chronic obstructive pulmonary disease (COPD) was registered to be the third leading cause of death worldwide in 2019, causing 3.23 million deaths. Tobacco smoking accounts for over 70% of COPD cases in high-income countries. Moreover, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed to the fact that aging is associated with multiple structural changes in the respiratory system, resulting in increased susceptibility to respiratory diseases. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. With increasing aged population, the incidence of respiratory conditions is expected to rise significantly. Furthermore, increase in trend toward home-based respiratory care allows patients to manage chronic conditions comfortably at home, reducing the need for hospital visits. Integration of smart technology in respiratory care devices, such as Bluetooth connectivity, remote monitoring, and data analytics, further allows for better management and tracking of respiratory health. However, high cost associated with these devices hampers the market growth. Acquiring and deploying
these devices further incur additional expenses, which deter the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access restrain the market growth. On the contrary, increase in government initiatives to provide access to cutting-edge respiratory care services is expected to offer remunerative opportunities for the expansion of the market during the forecast period. In addition, manufacturers are integrating diagnostic features such as built-in pulse oximetry and spirometry in respiratory care devices that will enable comprehensive respiratory monitoring, which is expected to open new avenues for the growth of the market during the forecast period.
The global respiratory care devices market is segmented into product, end user, and region. On the basis of product, the market is fragmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. Depending on end user, it is segregated into hospitals and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Competition Analysis
Competitive analysis and profiles of the major players in the global respiratory care devices market include Masimo, Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Becton, Dickinson and Company, Medtronic, ResMed, Hamilton Medical, Chart Industries, and Invacare Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Therapeutic Devices
- Positive airway pressure (PAP) devices
? Continuous Positive Airway Pressure (CPAP) Devices
? Bilevel PAP (BPAP) devices
? Automatic positive airway pressure (APAP) devices
- Mask
? Nasal masks
? Full-face masks
? Nasal pillow masks
? Oral masks
- Ventilators
? Adult ventilator
? Infant/neonatal ventilator
- Nebulizers
- Humidifiers
- Oxygen concentrators
? Fixed oxygen concentrators
? Portable oxygen concentrators
- Inhalers
- Reusable Resuscitators
- Nitric oxide delivery units
- Capnographs
- Gas analyzers
- Oxygen hoods
- Monitoring Devices
- Pulse oximeters
? Pediatric pulse oximeters
? Wrist-worn pulse oximeters
? Hand-held pulse oximeters
? Fingertip pulse oximeters
? Table-top/bedside pulse oximeters
- Diagnostic Devices
- Spirometers
- Polysomnography (PSG) devices
- Peak flow meters
- Consumables and Accessories
- Disposable masks
- Disposable resuscitators
- Tracheostomy tubes
- Nasal cannulas
- Others
By End User
- Hospitals
- Home Care
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Masimo
- Fisher & Paykel Healthcare Limited.
- Koninklijke Philips N.V.
- Dragerwerk AG & Co. KGaA
- Becton, Dickinson and Company
- Medtronic
- ResMed
- Hamilton Medical
- Chart Industries
- Invacare Corporation
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: SPINE BIOLOGICS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Spinal Allografts
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Bone Graft Substitutes
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Cell-Based Matrix
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: SPINE BIOLOGICS MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Outpatient Facilities
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: SPINE BIOLOGICS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Spine Biologics Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Spine Biologics Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Spine Biologics Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Spine Biologics Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Spine Biologics Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Spine Biologics Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Spine Biologics Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Spine Biologics Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Spine Biologics Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Spine Biologics Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Spine Biologics Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End User
6.4.7. Australia Spine Biologics Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End User
6.4.8. India Spine Biologics Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Spine Biologics Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Spine Biologics Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Spine Biologics Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Spine Biologics Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Spine Biologics Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Spine Biologics Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Stryker Corporation
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. NuVasive, Inc.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Orthofix
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Johnson And Johnson
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Exactech, Inc
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Zimmer Biomet Holding, Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Arthrex, Inc.
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Medtronic Plc
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Organogenesis Inc
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Kuros Biosciences
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. RESPIRATORY CARE DEVICES MARKET FOR THERAPEUTIC DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. RESPIRATORY CARE DEVICES MARKET FOR MONITORING DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. RESPIRATORY CARE DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. RESPIRATORY CARE DEVICES MARKET FOR CONSUMABLES AND ACCESSORIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. GLOBAL RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 7. RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. RESPIRATORY CARE DEVICES MARKET FOR HOME CARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. RESPIRATORY CARE DEVICES MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 12. NORTH AMERICA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 13. U.S. RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 14. U.S. RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 15. CANADA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 16. CANADA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. MEXICO RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 18. MEXICO RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 21. EUROPE RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 22. GERMANY RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 23. GERMANY RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. FRANCE RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 25. FRANCE RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. UK RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 27. UK RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 28. ITALY RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 29. ITALY RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. SPAIN RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 31. SPAIN RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. REST OF EUROPE RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 33. REST OF EUROPE RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 36. ASIA-PACIFIC RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. JAPAN RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 38. JAPAN RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 39. CHINA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 40. CHINA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. INDIA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 42. INDIA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. SOUTH KOREA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 44. SOUTH KOREA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. AUSTRALIA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 46. AUSTRALIA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 47. REST OF ASIA-PACIFIC RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 48. REST OF ASIA-PACIFIC RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 51. LAMEA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. BRAZIL RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 53. BRAZIL RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. SAUDI ARABIA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 55. SAUDI ARABIA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. SOUTH AFRICA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 57. SOUTH AFRICA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. REST OF LAMEA RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 59. REST OF LAMEA RESPIRATORY CARE DEVICES MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 60. MASIMO: KEY EXECUTIVES
TABLE 61. MASIMO: COMPANY SNAPSHOT
TABLE 62. MASIMO: OPERATING SEGMENTS
TABLE 63. MASIMO: PRODUCT PORTFOLIO
TABLE 64. MASIMO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65. FISHER AND PAYKEL HEALTHCARE LIMITED.: KEY EXECUTIVES
TABLE 66. FISHER AND PAYKEL HEALTHCARE LIMITED.: COMPANY SNAPSHOT
TABLE 67. FISHER AND PAYKEL HEALTHCARE LIMITED.: OPERATING SEGMENTS
TABLE 68. FISHER AND PAYKEL HEALTHCARE LIMITED.: PRODUCT PORTFOLIO
TABLE 69. FISHER AND PAYKEL HEALTHCARE LIMITED.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 70. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 71. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 72. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
TABLE 73. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 74. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75. DRaGERWERK AG AND CO. KGAA: KEY EXECUTIVES
TABLE 76. DRaGERWERK AG AND CO. KGAA: COMPANY SNAPSHOT
TABLE 77. DRaGERWERK AG AND CO. KGAA: OPERATING SEGMENTS
TABLE 78. DRaGERWERK AG AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 79. DRaGERWERK AG AND CO. KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 80. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 81. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 82. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 83. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 84. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 85. MEDTRONIC: KEY EXECUTIVES
TABLE 86. MEDTRONIC: COMPANY SNAPSHOT
TABLE 87. MEDTRONIC: OPERATING SEGMENTS
TABLE 88. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 89. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 90. RESMED: KEY EXECUTIVES
TABLE 91. RESMED: COMPANY SNAPSHOT
TABLE 92. RESMED: OPERATING SEGMENTS
TABLE 93. RESMED: PRODUCT PORTFOLIO
TABLE 94. RESMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. HAMILTON MEDICAL: KEY EXECUTIVES
TABLE 96. HAMILTON MEDICAL: COMPANY SNAPSHOT
TABLE 97. HAMILTON MEDICAL: OPERATING SEGMENTS
TABLE 98. HAMILTON MEDICAL: PRODUCT PORTFOLIO
TABLE 99. HAMILTON MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. CHART INDUSTRIES: KEY EXECUTIVES
TABLE 101. CHART INDUSTRIES: COMPANY SNAPSHOT
TABLE 102. CHART INDUSTRIES: OPERATING SEGMENTS
TABLE 103. CHART INDUSTRIES: PRODUCT PORTFOLIO
TABLE 104. CHART INDUSTRIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. INVACARE CORPORATION: KEY EXECUTIVES
TABLE 106. INVACARE CORPORATION: COMPANY SNAPSHOT
TABLE 107. INVACARE CORPORATION: OPERATING SEGMENTS
TABLE 108. INVACARE CORPORATION: PRODUCT PORTFOLIO
TABLE 109. INVACARE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL RESPIRATORY CARE DEVICES MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF RESPIRATORY CARE DEVICES MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN RESPIRATORY CARE DEVICES MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALRESPIRATORY CARE DEVICES MARKET
FIGURE 10. GLOBAL RESPIRATORY CARE DEVICES MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. RESPIRATORY CARE DEVICES MARKET FOR THERAPEUTIC DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. RESPIRATORY CARE DEVICES MARKET FOR MONITORING DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. RESPIRATORY CARE DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. RESPIRATORY CARE DEVICES MARKET FOR CONSUMABLES AND ACCESSORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. GLOBAL RESPIRATORY CARE DEVICES MARKET SEGMENTATION, BY END USER
FIGURE 16. RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. RESPIRATORY CARE DEVICES MARKET FOR HOME CARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 22. COMPETITIVE DASHBOARD
FIGURE 23. COMPETITIVE HEATMAP: RESPIRATORY CARE DEVICES MARKET
FIGURE 24. TOP PLAYER POSITIONING, 2023
FIGURE 25. MASIMO: NET SALES, 2021-2023 ($BILLION)
FIGURE 26. MASIMO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 27. MASIMO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 28. FISHER AND PAYKEL HEALTHCARE LIMITED.: NET SALES, 2021-2023 ($BILLION)
FIGURE 29. FISHER AND PAYKEL HEALTHCARE LIMITED.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. FISHER AND PAYKEL HEALTHCARE LIMITED.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. KONINKLIJKE PHILIPS N.V.: NET SALES, 2021-2023 ($BILLION)
FIGURE 32. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. DRaGERWERK AG AND CO. KGAA: NET SALES, 2021-2023 ($BILLION)
FIGURE 35. DRaGERWERK AG AND CO. KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. DRaGERWERK AG AND CO. KGAA: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
FIGURE 38. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 41. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. RESMED: NET SALES, 2021-2023 ($BILLION)
FIGURE 44. RESMED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. RESMED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. HAMILTON MEDICAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 47. HAMILTON MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. HAMILTON MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. CHART INDUSTRIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 50. CHART INDUSTRIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. CHART INDUSTRIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. INVACARE CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 53. INVACARE CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. INVACARE CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security